Recall of Elecsys Thyroglobulin assay used with the Elecsys Modular Analytics analysers An in vitro diagnostic medical device (IVD)

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Roche Diagnostics Australia Pty Limited.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2012-RN-01073-1
  • Event Risk Class
    Class II
  • Event Initiated Date
    2012-10-22
  • Event Country
  • Event Source
    DHTGA
  • Event Source URL
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    Roche have confirmed a positive bias of approximately 0.6 ng/ml with specific lots of the elecsys thyroglobulin assay.
  • Action
    Affected laboratories to be aware of the potential elevated Tg recovery using this reagent lot and closely monitor internal quality control results.

Device

  • Model / Serial
    Elecsys Thyroglobulin assay used with the Elecsys Modular Analytics analysers An in vitro diagnostic medical device (IVD)Material Number: 05118921-190 Lot Number: 16934601
  • Manufacturer

Manufacturer